Pharmaceutical treatment process using chitosan or derivative thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8709996
SERIAL NO

12766487

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a solid composition for oral administration comprising:

    (i) a drug compound;(ii) chitosan or a derivative thereof or a salt of chitosan or salt of a derivative of chitosan; and(iii) an organic acid.Preferably the drug compound is a polar molecule having a molecular weight of 1 KDa or less, a peptide, a protein or a polysaccharide. The compositions of the invention provide enhance absorption of the drug compound.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ARCHIMEDES DEVELOPMENT LIMITEDNOTTINGHAM NG7 2TN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Illum, Lisbeth Nottingham, GB 51 2513
Leane, Michael Merseyside, GB 2 23
Smith, Alan Nottingham, GB 148 2170

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 29, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00